US Patent Issued to Beijing Konruns Pharmaceutical on May 6 for "Crystalline form of compound, method for preparing the same, pharmaceutical composition and use" (Chinese Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,503, issued on May 6, was assigned to Beijing Konruns Pharmaceutical Co. Ltd. (Beijing).

"Crystalline form of compound, method for preparing the same, pharmaceutical composition and use" was invented by Xiaohua Sun (Beijing), Long Wang (Beijing), Hongzhen Yang (Beijing) and Huaizhong Hu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to the field of pharmaceutical technology, providing three crystalline forms, i.e., a crystalline form AB, a crystalline form M and a crystalline form F, of the compound 6-[[4-[2-fluoro-4-[[1-[(4-fluorophenyl)aminoformyl]cyclopropanecarbonyl]-amino]phenoxy]-6-methoxy-7-quinolyl]oxy...